The DOI matches its Crossref record.
Drug Delivery and Targeting
Abstract
When a pharmaceutical agent is encapsulated within, or attached to, a polymer or lipid, drug safety and efficacy can be greatly improved and new therapies are possible. This has provided the impetus for active study of the design of degradable materials, intelligent delivery systems and approaches for delivery through different portals in the body.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Items 201–238 of 238
Han, S.-S., Li, Z.-Y., Zhu, J.-Y., Han, K., Zeng, Z.-Y., Hong, W., Li, W.-X., Jia, H.-Z., Liu, Y., Zhuo, R.-X., et al. (2015) · Small · doi:10.1002/smll.201402865 · Cited by 269
Grage, K., Jahns, A. C., Parlane, N., Palanisamy, R., Rasiah, I. A., Atwood, J. A., & Rehm, B. H. A. (2009) · Biomacromolecules · doi:10.1021/bm801394s · Cited by 267
Bergström, J. S., & Hayman, D. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1455-8 · Cited by 266
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Lai, S. K., Hida, K., Man, S. T., Chen, C., Machamer, C., Schroer, T. A., & Hanes, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.021 · Cited by 264
Choi, K. Y., Saravanakumar, G., Park, J. H., & Park, K. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.10.029 · Cited by 264
Matrices and scaffolds for DNA delivery in tissue engineering
De Laporte, L., & Shea, L. D. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.017 · Cited by 258
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
Fulton, M. D., & Najahi-Missaoui, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076615 · Cited by 258
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
Functional Polymeric Microparticles Engineered from Controllable Microfluidic Emulsions
Wang, W., Zhang, M.-J., & Chu, L.-Y. (2014) · Accounts of Chemical Research · doi:10.1021/ar4001263 · Cited by 255
Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions
Traitel, T., Cohen, Y., & Kost, J. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00050-8 · Cited by 253
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D., Rhee, J.-W., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 253
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery
Patil, Y. B., Toti, U. S., Khdair, A., Ma, L., & Panyam, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.056 · Cited by 242
Incorporation of heparin into biomaterials
Sakiyama-Elbert, S. E. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.08.045 · Cited by 222
Pappalardo, D., Annunziata, L., & Pellecchia, C. (2009) · Macromolecules · doi:10.1021/ma9010439 · Cited by 199
Gu, Y., Zhong, Y., Meng, F., Cheng, R., Deng, C., & Zhong, Z. (2013) · Biomacromolecules · doi:10.1021/bm400615n · Cited by 187
Jeong, S. I., Kim, B.-S., Lee, Y. M., Ihn, K. J., Kim, S. H., & Kim, Y. H. (2004) · Biomacromolecules · doi:10.1021/bm049921i · Cited by 182
Hung, L.-H., Teh, S.-Y., Jester, J., & Lee, A. P. (2010) · Lab on a Chip · doi:10.1039/c002866e · Cited by 171
Leveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Synthesis and Characterization of Poly(l-lactide)−Poly(ε-caprolactone) Multiblock Copolymers
Jeon, O., Lee, S.-H., Kim, S. H., Lee, Y. M., & Kim, Y. H. (2003) · Macromolecules · doi:10.1021/ma034006v · Cited by 168
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b00376 · Cited by 155
Jusu, S. M., Obayemi, J. D., Salifu, A. A., Nwazojie, C. C., Uzonwanne, V., Odusanya, O. S., & Soboyejo, W. O. (2020) · Scientific Reports · doi:10.1038/s41598-020-71129-0 · Cited by 112
Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies
Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2024.11.001 · Cited by 112
Constitutive Framework for Biodegradable Polymers with Applications to Biodegradable Stents
Soares, J. S., Moore, J. E., & Rajagopal, K. R. (2008) · ASAIO Journal · doi:10.1097/mat.0b013e31816ba55a · Cited by 106
Murakami, N., Saito, N., Horiuchi, H., Okada, T., Nozaki, K., & Takaoka, K. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10236 · Cited by 77
Targeted Drug Delivery via the Use of ECM-Mimetic Materials
Hwang, J., Sullivan, M. O., & Kiick, K. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00069 · Cited by 76
Modeling the pH-dependent PLA oligomer degradation kinetics
Lazzari, S., Codari, F., Storti, G., Morbidelli, M., & Moscatelli, D. (2014) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2014.08.012 · Cited by 61
Rieger, J., Passirani, C., Benoit, J. ‐., Van Butsele, K., Jérôme, R., & Jérôme, C. (2006) · Advanced Functional Materials · doi:10.1002/adfm.200500110 · Cited by 61
Synthetic tumor networks for screening drug delivery systems
Prabhakarpandian, B., Shen, M.-C., Nichols, J. B., Garson, C. J., Mills, I. R., Matar, M. M., Fewell, J. G., & Pant, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.018 · Cited by 57
Yakacki, C. M., Lyons, M. B., Rech, B., Gall, K., & Shandas, R. (2008) · Biomedical Materials · doi:10.1088/1748-6041/3/1/015010 · Cited by 50
Pappuru, S., Chokkapu, E. R., Chakraborty, D., & Ramkumar, V. (2013) · Dalton Transactions · doi:10.1039/c3dt52065j · Cited by 47
Topology mediates transport of nanoparticles in macromolecular networks
Dai, X., Zhang, X., Gao, L., Xu, Z., & Yan, L.-T. (2022) · Nature Communications · doi:10.1038/s41467-022-31861-9 · Cited by 44
Navarro-Baena, I., Marcos-Fernández, A., Fernández-Torres, A., Kenny, J. M., & Peponi, L. (2014) · RSC Advances · doi:10.1039/c3ra44786c · Cited by 43
Liu, F., Zhao, Z., Yang, J., Wei, J., & Li, S. (2009) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2008.10.023 · Cited by 29
Rivera, K. O., Cuylear, D. L., Duke, V. R., O’Hara, K. M., Zhong, J. X., Elghazali, N. A., Finbloom, J. A., Kharbikar, B. N., Kryger, A. N., Miclau, T., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1190371 · Cited by 22
Metadata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.